The study used data on US veterans with type 2 diabetes, some of whom were given Ozempic or Wegovy and some more standard drugs – to measure their effect on 175 other illnesses.
There appeared to be a significant boon to heart health, with lower levels of heart attacks, stroke, heart failure and high blood pressure, in those taking the new weight-loss drugs.
They also cut the risk of substance abuse (including alcohol, opioids and cannabis) as well as reducing schizophrenia, suicidal thoughts and seizures.
Despite the study being short, and people taking the drugs for only 3.5 years because of how new they are, it reported a 12% reduction in Alzheimer’s disease.
There was also less liver cancer, muscle pain and chronic kidney disease as well as a noted reduction in bacterial infections and fever.
On the flip side, people were more likely to have problems in their digestive system. Feeling sick, tummy pain, inflammation in the stomach, diverticulitis (bulges in the intestines that can be painful) and haemorrhoids were more common on Ozempic or Wegovy.
Merck and Moderna are calling this a personalised vaccine, meaning it works by targeting an…
Verified videos show the aftermath of Tuesday and Wednesday's strikes in Gaza City which show…
Israel has built about 160 settlements housing 700,000 Jews since it occupied the West Bank…
The vaccination of commercial hens against common salmonella strains, which began in the mid-1990s in…
The Israeli army has ordered a criminal investigation into the killing in Gaza of five-year-old…
A person has died and hundreds have fallen ill with salmonella food poisoning in an…